Safety Issues clinical trials

Explore recruiting safety issues clinical trials.

Recruiting safety issues studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Safety Issues trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1/2a, Open-Label, Non-Randomized, Dose-Escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects with Retinitis Pigmentosa.

France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Randomized, placebo-controlled, double-blind study to evaluate the efficacy of 2LHERP® in patients with recurrent orofacial herpes infections.

Belgium

Therapeutic use (Phase IV) EU CTIS Study details

Randomized, placebo-controlled, double-blind study to evaluate the efficacy of 2LVERU®JUNIOR and 2LVERU® on the treatment of warts.

Belgium

Phase III and phase IV (Integrated) EU CTIS Study details

Randomised placebo controlled clinical trial of efficacy of MYOcardial protection in postacute inFLAMmatory cardiac involvEment due to COVID-19 (MYOFLAME-19)

Austria, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

DUMELEP trial - Durvalumab (MEDI4736)/Tremelimumab in neoadjuvant and adjuvant setting in patients with HCC treated by percutaneous ablation procedure in curative intent

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Randomized, placebo-controlled, double-blind study to evaluate the efficacy of 2LEBV® and 2LXFS® on asthenia in patients with an EBV infection

Belgium

Therapeutic use (Phase IV) EU CTIS Study details

Safety Issues trials by city

Safety Issues in Toronto Safety Issues in Vancouver Safety Issues in Montreal Safety Issues in Calgary Safety Issues in Edmonton Safety Issues in Ottawa Safety Issues in Winnipeg Safety Issues in Quebec City Safety Issues in Hamilton Safety Issues in Kitchener Safety Issues in London Safety Issues in Halifax Safety Issues in New York Safety Issues in Los Angeles Safety Issues in Chicago Safety Issues in Houston

Safety Issues clinical trials

Recruiting safety issues studies right now

Phase I Study to Evaluate KP405 in Healthy and Parkinson's Disease Patients

Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Study

Early De-escalation of Empirical Antibiotics Treatment for Neutropenic Fever

Safety, Tolerability, PK and PD of SSS55 in Healthy Subjects

NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors

Evaluation of Performance, Safety and Benefit of the Wishbone HA as Bone Graft Substitute, a Pre-market Clinical Investigation

BeSMART Secure Storage Counseling in the Inpatient Setting

DCB Versus Primary Selective Stenting in TASC C/D Femoropopliteal Artery Disease

Also recruiting in Europe

A Phase 1/2a, Open-Label, Non-Randomized, Dose-Escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects with Retinitis Pigmentosa.

Randomized, placebo-controlled, double-blind study to evaluate the efficacy of 2LHERP® in patients with recurrent orofacial herpes infections.

Randomized, placebo-controlled, double-blind study to evaluate the efficacy of 2LVERU®JUNIOR and 2LVERU® on the treatment of warts.

Randomised placebo controlled clinical trial of efficacy of MYOcardial protection in postacute inFLAMmatory cardiac involvEment due to COVID-19 (MYOFLAME-19)

DUMELEP trial - Durvalumab (MEDI4736)/Tremelimumab in neoadjuvant and adjuvant setting in patients with HCC treated by percutaneous ablation procedure in curative intent

Randomized, placebo-controlled, double-blind study to evaluate the efficacy of 2LEBV® and 2LXFS® on asthenia in patients with an EBV infection

Safety Issues trials by city

Other conditions